HC Wainwright Reiterates Buy Rating on Eton Pharmaceuticals
HC Wainwright & Co. reiterated its Buy rating and $70 price target on Eton Pharmaceuticals. The target implies 31.3% upside from the Oct. 13 close of $53.33.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.